These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37899721)

  • 1. HIV Preexposure Prophylaxis Provision among Adolescents: 2018 to 2021.
    Kimball AA; Zhu W; Leonard J; Wei W; Ravichandran I; Tanner MR; Huang YA; Hoover KW; Kourtis AP
    Pediatrics; 2023 Nov; 152(5):. PubMed ID: 37899721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
    Tanner MR; Miele P; Carter W; Valentine SS; Dunville R; Kapogiannis BG; Smith DK
    MMWR Recomm Rep; 2020 Apr; 69(3):1-12. PubMed ID: 32324724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the Number and Characteristics of HIV Pre-Exposure Prophylaxis Providers in the United States, 2014-2019.
    Zhu W; Huang YA; Kourtis AP; Hoover KW
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):282-289. PubMed ID: 34651603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescent Health Providers' Willingness to Prescribe Pre-Exposure Prophylaxis (PrEP) to Youth at Risk of HIV Infection in the United States.
    Hart-Cooper GD; Allen I; Irwin CE; Scott H
    J Adolesc Health; 2018 Aug; 63(2):242-244. PubMed ID: 29843969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa.
    Jamieson L; Gomez GB; Rebe K; Brown B; Subedar H; Jenkins S; Shoko N; Bekker LG; Johnson LF; Meyer-Rath G
    AIDS; 2020 May; 34(6):883-891. PubMed ID: 32004205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.
    Mullins TLK; Zimet G; Lally M; Xu J; Thornton S; Kahn JA
    AIDS Patient Care STDS; 2017 Dec; 31(12):504-516. PubMed ID: 29211514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.
    Chan SS; Chappel AR; Maddox KEJ; Hoover KW; Huang YA; Zhu W; Cohen SM; Klein PW; De Lew N
    PLoS Med; 2020 Apr; 17(4):e1003072. PubMed ID: 32275654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.
    Wu H; Mendoza MC; Huang YA; Hayes T; Smith DK; Hoover KW
    Clin Infect Dis; 2017 Jan; 64(2):144-149. PubMed ID: 27986691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Preexposure Prophylaxis Among Adolescents in the US: A Review.
    Yusuf H; Fields E; Arrington-Sanders R; Griffith D; Agwu AL
    JAMA Pediatr; 2020 Nov; 174(11):1102-1108. PubMed ID: 32391878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.
    Sullivan PS; Giler RM; Mouhanna F; Pembleton ES; Guest JL; Jones J; Castel AD; Yeung H; Kramer M; McCallister S; Siegler AJ
    Ann Epidemiol; 2018 Dec; 28(12):833-840. PubMed ID: 30037634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider Comfort with Prescribing HIV Pre-Exposure Prophylaxis to Adolescents.
    Pina P; Taggart T; Sanchez Acosta M; Eweka I; Muñoz-Laboy M; Albritton T
    AIDS Patient Care STDS; 2021 Oct; 35(10):411-417. PubMed ID: 34623888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence With Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States, 2012-2017.
    Huang YA; Tao G; Smith DK; Hoover KW
    Clin Infect Dis; 2021 Feb; 72(3):379-385. PubMed ID: 33527117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort.
    Mounzer KC; Fusco JS; Hsu RK; Brunet L; Vannappagari V; Frost KR; Shaefer MS; Rinehart A; Rawlings K; Fusco GP
    AIDS Patient Care STDS; 2021 Nov; 35(11):419-427. PubMed ID: 34609897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted Effectiveness of Daily and Nondaily Preexposure Prophylaxis for Men Who Have Sex With Men Based on Sex and Pill-taking Patterns From the Human Immuno Virus Prevention Trials Network 067/ADAPT Study.
    Dimitrov D; Moore JR; Wood D; Mitchell KM; Li M; Hughes JP; Donnell DJ; Mannheimer S; Holtz TH; Grant RM; Boily MC
    Clin Infect Dis; 2020 Jul; 71(2):249-255. PubMed ID: 31437276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation Factors Associated With Primary Care Providers' Intention to Prescribe HIV PrEP to Adolescents in the United States.
    Owens C; Currin JM; Hoffman M; Grant MJ; Hubach RD
    J Adolesc Health; 2023 Jul; 73(1):181-189. PubMed ID: 37031092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
    Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
    Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing HIV Infection in High-Risk Adolescents Using Preexposure Prophylaxis (PrEP).
    Blackwell CW
    J Assoc Nurses AIDS Care; 2018; 29(5):770-774. PubMed ID: 30146018
    [No Abstract]   [Full Text] [Related]  

  • 20. Acceptability and Barriers to HIV Pre-Exposure Prophylaxis in Atlanta's Adolescents and Their Parents.
    Shah M; Gillespie S; Holt S; Morris CR; Camacho-Gonzalez AF
    AIDS Patient Care STDS; 2019 Oct; 33(10):425-433. PubMed ID: 31436485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.